NORML

JANUARY 28, 2019

The New York State Association of Police said traffic safety is a major concern, citing an increase in vehicle-related fatalities by 62 percent in Colorado the first year cannabis was legalized in the state. Change ( +/-) from previous year. 1 year prior to legalization. Sales began January 1.

Legalization 202

Legalization Marijuana Data Safety 202

Veriheal

NOVEMBER 30, 2021

Johnson’s work with psychedelics began back in 2004, according to the Johns Hopkins website. In 2008, he published psychedelic safety guidelines. He conducted the first blinded human research study into the psychoactive effects of salvinorin A in 2011 and published data on MDMA pill testing services in 2017.

Research and Development 98

Research and Development Therapy Data Treatment 98

Cannabis Law Report

MARCH 9, 2019

London law firm Mackrell Turner Garrett, together with a leading food and trading standards barrister, were instructed by the Cannabis Trades Association UK (CTA) to make representations to the European Food Safety Authority (EFSA).

CBD 87

CBD Food Seed-To-Sale Extraction 87

Cannabis Law Report

APRIL 8, 2022

The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

SpeedWeed

AUGUST 10, 2021

Many regulated markets mandate indoor cultivation of marijuana for “security” and “safety” reasons, but the downside is that more energy is needed to support this type of production. According to cannabis analytics firm New Frontier Data , legal and illicit cannabis crops used around 2.8 Support companies doing the work.

Packaging 40

Packaging Environment Cultivation Hash 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Data collection.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45